Palantir's Bold Biosecurity Opportunity Could Boost Returns
Palantir sits at a crossroads of defense data and biotech action. This article explores why palantir's bold biosecuri...
New to investing? Check out these zero fee investment apps designed specifically for new investors to start building wealth.
28,005 articlesPalantir sits at a crossroads of defense data and biotech action. This article explores why palantir's bold biosecuri...
Navan stock down from its IPO price has dropped sharply, but a major investor just built a substantial stake. Here’s ...
A new stake in WEX highlights growing confidence in fintech payments as the company reports record revenue. This anal...
A focused look at OmniAb's Q4 2025 earnings and what the numbers could mean for investors. Discover the drivers, risk...
A sharp drop in Alphabet shares doesn’t erase its long-term potential. This guide explains why Buffett’s approach and...
A strong quarter from TSMC is more than a one-off beat. This analysis explains why tsmc's revenue grew last and how c...
After a quarterly report, Netflix's post-earnings sell-off just highlighted a shift in strategy. This article breaks ...
As Taysha prepares to share Q4 2025 results, investors search for clarity on cash runway, pipeline progress, and futu...
A big stake in Sotera Health has caught the market's eye as shares slide. This article breaks down what a $175 millio...
Berkshire Hathaway buying back its own stock marks a notable shift in how the company uses cash. Even a modest repurc...
As ELAN reports Q1 2026 earnings, investors want clarity on growth, margins, and guidance. This analysis breaks down ...
A major institutional move signals a shift in risk tolerance and strategy. Learn what arcus capital scales back means...